Protective Role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases

Antioxidants and Redox Signaling

Volumn 20, Issue 2, 2014, Pages 217-235

  Muñoz Lobato, Fernando ^a   Rodríguez Palero, María Jesús ^a   Naranjo Galindo, Francisco José ^a   Shephard, Freya ^b   Gaffney, Christopher J ^b   Szewczyk, Nathaniel J ^b   Hamamichi, Shusei ^c   Caldwell, Kim A ^c   Caldwell, Guy A ^c   Link, Chris D ^d   Miranda Vizuete, Antonio ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF ALABAMA   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; CELL PROTEIN; CYTOPLASM PROTEIN; DNJ 27 PROTEIN; ENDOPLASMIC RETICULUM DJ5 PROTEIN; POLYGLUTAMINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; HUNTINGTON CHOREA; MITOCHONDRION; MOUSE; NEUROPROTECTION; NONHUMAN; ORTHOLOGY; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; RNA INTERFERENCE;

ALPHA-SYNUCLEIN; AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; AUTOPHAGY; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HSP40 HEAT-SHOCK PROTEINS; HUMANS; MITOCHONDRIA; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISEASES; PEPTIDES; PHENOTYPE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; RNA INTERFERENCE;

EID: 84891816134     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.5051     Document Type: Article

References (90)

1. Apfeld J and Kenyon C. Regulation of lifespan by sensory perception in Caenorhabditis elegans. Nature 402: 804-809, 1999.
2. Arrasate M, Mitra S, Schweitzer ES, Segal MR, and Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431: 805-810, 2004.
3. Berkowitz LA, Hamamichi S, Knight AL, Harrington AJ, Caldwell GA, and Caldwell KA. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinsons disease genes. J Vis Exp Pii: 835, 2008.
4. Boyd-Kimball D, Poon HF, Lynn BC, Cai J, Pierce WM, Jr., Klein JB, Ferguson J, Link CD, and Butterfield DA. Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Abeta(1-42): implications for Alzheimers disease. Neurobiol Aging 27: 1239-1249, 2006.
5. Buchberger A, Bukau B, and Sommer T. Protein quality control in the cytosol and the endoplasmic reticulum: brothers in arms. Mol Cell 40: 238-252, 2010.
6. Cacho-Valadez B, Munoz-Lobato F, Pedrajas JR, Cabello J, Fierro-Gonzalez JC, Navas P, Swoboda P, Link CD, and Miranda-Vizuete A. The characterization of the Caenorhabditis elegans mitochondrial thioredoxin system uncovers an unexpected protective role of thioredoxin reductase 2 in beta-Amyloid peptide toxicity. Antioxid Redox Signal 16: 1384-1400, 2012.
7. Cao S, Gelwix CC, Caldwell KA, and Caldwell GA. Torsinmediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J Neurosci 25: 3801-3812, 2005.
8. Cohen E, Bieschke J, Perciavalle RM, Kelly JW, and Dillin A. Opposing activities protect against age-onset proteotoxicity. Science 313: 1604-1610, 2006.
9. Cohen E, Du D, Joyce D, Kapernick EA, Volovik Y, Kelly JW, andDillin A. Temporal requirements of insulin/IGF-1 signaling for proteotoxicity protection. Aging Cell 9: 126-134, 2010.
10. Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, Liu K, Xu K, Strathearn KE, Liu F, Cao S, Caldwell KA, Caldwell GA, Marsischky G, Kolodner RD, Labaer J, Rochet JC, Bonini NM, and Lindquist S. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinsons models. Science 313: 324-328, 2006.
11. Cunnea PM, Miranda-Vizuete A, Bertoli G, Simmen T, Damdimopoulos AE, Hermann S, Leinonen S, Huikko MP, Gustafsson JA, Sitia R, and Spyrou G. ERdj5, an endoplasmic reticulum (ER)-resident protein containing DnaJ and thioredoxin domains, is expressed in secretory cells or following ER stress. J Biol Chem 278: 1059-1066, 2003.
12. Drake J, Link CD, and Butterfield DA. Oxidative stress precedes fibrillar deposition of Alzheimers disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiol Aging 24: 415-420, 2003.
13. Duennwald ML and Lindquist S. Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity. Genes Dev 22: 3308-3319, 2008.
14. Estevez AO, Mueller CL, Morgan KL, Szewczyk NJ, Teece L, Miranda-Vizuete A, and Estevez M. Selenium induces cholinergic motor neuron degeneration in Caenorhabditis elegans. Neurotoxicology 33: 1021-1032, 2012.
15. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, and Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811, 1998.
16. Florez-McClure ML, Hohsfield LA, Fonte G, Bealor MT, and Link CD. Decreased insulin-receptor signaling promotes the autophagic degradation of beta-Amyloid peptide in C. elegans. Autophagy 3: 569-580, 2007.
17. Fonte V, Dostal V, Roberts CM, Gonzales P, Lacor P, Magrane J, Dingwell N, Fan EY, Silverman MA, Stein GH, and Link CD. A glycine zipper motif mediates the formation of toxic beta-Amyloid oligomers in vitro and in vivo. Mol Neurodegener 6: 61, 2011.
18. FonteV,KapulkinV, TaftA, Fluet A, Friedman D, and LinkCD. Interaction of intracellular beta amyloid peptidewith chaperone proteins. Proc Natl Acad Sci U S A 99: 9439-9444, 2002.
19. Fostel JL, Benner Coste L, and Jacobson LA. Degradation of transgene-coded and endogenous proteins in the muscles of Caenorhabditis elegans. Biochem Biophys Res Commun 312: 173-177, 2003.
20. Garsin DA, Villanueva JM, Begun J, Kim DH, Sifri CD, Calderwood SB, Ruvkun G, and Ausubel FM. Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science 300: 1921, 2003.
21. Gibson GE and Huang HM. Oxidative stress in Alzheimers disease. Neurobiol Aging 26: 575-578, 2005.
22. Gidalevitz T, Ben-Zvi A, Ho KH, Brignull HR, and Morimoto RI. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311: 1471-1474, 2006.
23. Gonzales PK and Link CD. Mitochondrial fission protects C. elegans from amyloid-beta toxicity. 18th International C. elegans Meeting Poster 394B, 2011.
24. Hagiwara M, Maegawa K, Suzuki M, Ushioda R, Araki K, Matsumoto Y, Hoseki J, Nagata K, and Inaba K. Structural basis of an ERAD pathway mediated by the ER-resident protein disulfide reductase ERdj5. Mol Cell 41: 432-444, 2011.
25. Hamamichi S, Rivas RN, Knight AL, Cao S, Caldwell KA, and Caldwell GA. Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinsons disease model. Proc Natl Acad Sci U S A 105: 728-733, 2008.
26. Hampton RY, Gardner RG, and Rine J. Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein. Mol Biol Cell 7: 2029-2044, 1996.
27. Hardy J and Selkoe DJ. The amyloid hypothesis of Alzheimers disease: progress and problems on the road to therapeutics. Science 297: 353-356, 2002.
28. Harman D. Aging: overview. Ann N Y Acad Sci 928: 1-21, 2001.
29. Harrington AJ, Hamamichi S, Caldwell GA, and Caldwell KA. C. elegans as a model organism to investigate molecular pathways involved with Parkinsons disease. Dev Dyn 239: 1282-1295, 2010.
30. Hayashi T and Su TP. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2 + ) signaling and cell survival. Cell 131: 596-610, 2007.
31. Hosoda A, Tokuda M, Akai R, Kohno K, and Iwawaki T. Positive contribution of ERdj5/JPDI to endoplasmic reticulum protein quality control in the salivary gland. Biochem J 425: 117-125, 2010.
32. Kamp F, Exner N, Lutz AK, Wender N, Hegermann J, Brunner B, Nuscher B, Bartels T, Giese A, Beyer K, Eimer S, Winklhofer KF, and Haass C. Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J 29: 3571-3589, 2010.
33. Kaneko M, Koike H, Saito R, Kitamura Y, Okuma Y, and Nomura Y. Loss of HRD1-mediated protein degradation causes amyloid precursor protein accumulation and amyloid-beta generation. J Neurosci 30: 3924-3932, 2010.
34. Khan LA, Bauer PO, Miyazaki H, Lindenberg KS, Landwehrmeyer BG, and Nukina N. Expanded polyglutamines impair synaptic transmission and ubiquitin-proteasome system in Caenorhabditis elegans. J Neurochem 98: 576-587, 2006.
35. Kirstein-Miles J and Morimoto RI. Caenorhabditis elegans as a model system to study intercompartmental proteostasis: Interrelation of mitochondrial function, longevity, and neurodegenerative diseases. Dev Dyn 239: 1529-1538, 2010.
36. Knittler MR, Dirks S, and Haas IG. Molecular chaperones involved in protein degradation in the endoplasmic reticulum: quantitative interaction of the heat shock cognate protein BiP with partially folded immunoglobulin light chains that are degraded in the endoplasmic reticulum. Proc Natl Acad Sci U S A 92: 1764-1768, 1995.
37. Labrousse AM, Zappaterra MD, Rube DA, and van der Bliek AM. C. elegans dynamin-related protein DRP-1 controls severing of the mitochondrial outer membrane. Mol Cell 4: 815-826, 1999.
38. Lehmann S, Shephard F, Jacobson LA, and Szewczyk NJ. Integrated control of protein degradation in muscle. Worm 1: 141-150, 2012.
39. Lehmann S, Shephard F, Jacobson LA, and Szewczyk NJ. Using multiple phenotype assays and epistasis testing to enhance the reliability of RNAi screening and identify regulators of muscle protein degradation. Genes (Basel) 3: 686-701, 2012.
40. Lewis MJ and Pelham HR. A human homologue of the yeast HDEL receptor. Nature 348: 162-163, 1990.
41. Link CD. Expression of human beta-Amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci U S A 92: 9368-9372, 1995.
42. Link CD, Johnson CJ, Fonte V, Paupard M, Hall DH, Styren S, Mathis CA, and Klunk WE. Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. Neurobiol Aging 22: 217-226, 2001.
43. Link CD, Taft A, Kapulkin V, Duke K, Kim S, Fei Q, Wood DE, and Sahagan BG. Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimers disease model. Neurobiol Aging 24: 397-413, 2003.
44. Ma Y and Hendershot LM. The unfolding tale of the unfolded protein response. Cell 107: 827-830, 2001.
45. Maier W, Adilov B, Regenass M, and Alcedo J. A neuromedin U receptor acts with the sensory system to modulate food type-dependent effects on C elegans lifespan. PLoS Biol 8: e1000376, 2010.
46. Mello CC, Kramer JM, Stinchcomb D, and Ambros V. Efficient gene transfer in C. elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J 10: 3959-3970, 1991.
47. Morley JF, Brignull HR, Weyers JJ, and Morimoto RI. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A 99: 10417-10422, 2002.
48. Mouysset J, Kahler C, and Hoppe T. A conserved role of Caenorhabditis elegans CDC-48 in ER-Associated protein degradation. J Struct Biol 156: 41-49, 2006.
49. Nollen EA, Garcia SM, van Haaften G, Kim S, Chavez A, Morimoto RI, and Plasterk RH. Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci U S A 101: 6403-6408, 2004.
50. Orr HT and Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci 30: 575-621, 2007.
51. Pivtoraiko VN, Harrington AJ, Mader BJ, Luker AM, Caldwell GA, Caldwell KA, Roth KA, and Shacka JJ. Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction. J Neurochem 114: 1193-1204, 2010.
52. Priyadarshi A, Khuder SA, Schaub EA, and Priyadarshi SS. Environmental risk factors and Parkinsons disease: a metaanalysis. Environ Res 86: 122-127, 2001.
53. Ramesh BN, Rao TS, Prakasam A, Sambamurti K, and Rao KS. Neuronutrition and Alzheimers disease. J Alzheimers Dis 19: 1123-1139, 2010.
54. Reddy PH and Reddy TP. Mitochondria as a therapeutic target for aging and neurodegenerative diseases. Curr Alzheimer Res 8: 393-409, 2011.
55. Reinke SN, Hu X, Sykes BD, and Lemire BD. Caenorhabditis elegans diet significantly affects metabolic profile, mitochondrial DNA levels, lifespan and brood size. Mol Genet Metab 100: 274-282, 2010.
56. Ross CA and Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med 10 Suppl: S10-S17, 2004.
57. Sasagawa Y, Yamanaka K, and Ogura T. ER E3 ubiquitin ligase HRD-1 and its specific partner chaperone BiP play important roles in ERAD and developmental growth in Caenorhabditis elegans. Genes Cells 12: 1063-1073, 2007.
58. Satyal SH, Schmidt E, Kitagawa K, Sondheimer N, Lindquist S, Kramer JM, and Morimoto RI. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc Natl Acad Sci U S A 97: 5750-5755, 2000.
59. Schaheen B, Dang H, and Fares H. Derlin-dependent accumulation of integral membrane proteins at cell surfaces. J Cell Sci 122: 2228-2239, 2009.
60. Schekman R. Cell biology: a channel for protein waste. Nature 429: 817-818, 2004.
61. Shen X, Ellis RE, Lee K, Liu CY, Yang K, Solomon A, Yoshida H, Morimoto R, Kurnit DM, Mori K, and Kaufman RJ. Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. Cell 107: 893-903, 2001.
62. Shephard F, Adenle AA, Jacobson LA, and Szewczyk NJ. Identification and functional clustering of genes regulating muscle protein degradation from amongst the known C. elegans muscle mutants. PLoS One 6: e24686, 2011.
63. Silva MC, Fox S, Beam M, Thakkar H, Amaral MD, and Morimoto RI. A genetic screening strategy identifies novel regulators of the proteostasis network. PLoS Genet 7: e1002438, 2011.
64. Simmen T, Aslan JE, Blagoveshchenskaya AD, Thomas L, Wan L, Xiang Y, Feliciangeli SF, Hung CH, Crump CM, and Thomas G. PACS-2 controls endoplasmic reticulum-mitochondria communication and Bid-mediated apoptosis. EMBO J 24: 717-729, 2005.
65. Simmer F, Tijsterman M, Parrish S, Koushika SP, Nonet ML, Fire A, Ahringer J, and Plasterk RH. Loss of the putative RNA-directed RNA polymerase RRF-3 makes C. elegans hypersensitive to RNAi. Curr Biol 12: 1317-1319, 2002.
66. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, and Gwinn-Hardy K. Alpha-Synuclein locus triplication causes Parkinsons disease. Science 302: 841, 2003.
67. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, and Goedert M. Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinsons disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 95: 6469-6473, 1998.
68. Su B, Wang X, Zheng L, Perry G, Smith MA, and Zhu X. Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim Biophys Acta 1802: 135-142, 2010.
69. Sulston J and Hodgkin J. Methods. In: The Nematode Caenorhabditis elegans. edited by Press CSHL. New York: Cold Spring Harbor, 1988, pp.587-606.
70. Szabadkai G, Bianchi K, Varnai P, De Stefani D, Wieckowski MR, Cavagna D, Nagy AI, Balla T, and Rizzuto R. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2 + channels. J Cell Biol 175: 901-911, 2006.
71. Szewczyk NJ, Peterson BK, Barmada SJ, Parkinson LP, and Jacobson LA. Opposed growth factor signals control protein degradation in muscles of Caenorhabditis elegans. EMBO J 26: 935-943, 2007.
72. Szewczyk NJ, Peterson BK, and Jacobson LA. Activation of Ras and the mitogen-Activated protein kinase pathway promotes protein degradation in muscle cells of Caenorhabditis elegans. Mol Cell Biol 22: 4181-4188, 2002.
73. Tanner CM. Is the cause of Parkinsons disease environmental or hereditary? Evidence from twin studies. Adv Neurol 91: 133-142, 2003.
74. Taylor JP, Hardy J, and Fischbeck KH. Toxic proteins in neurodegenerative disease. Science 296: 1991-1995, 2002.
75. Tian Y, Li Z, Hu W, Ren H, Tian E, Zhao Y, Lu Q, Huang X, Yang P, Li X, Wang X, Kovacs AL, Yu L, and Zhang H. C elegans screen identifies autophagy genes specific to multicellular organisms. Cell 141: 1042-1055, 2010.
76. Travers KJ, Patil CK, Wodicka L, Lockhart DJ, Weissman JS, and Walter P. Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-Associated degradation. Cell 101: 249-258, 2000.
77. Treusch S, Cyr DM, and Lindquist S. Amyloid deposits: protection against toxic protein species? Cell Cycle 8: 1668-1674, 2009.
78. Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, and Lipton SA. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441: 513-517, 2006.
79. Urano F, Calfon M, Yoneda T, Yun C, Kiraly M, Clark SG, and Ron D. A survival pathway for Caenorhabditis elegans with a blocked unfolded protein response. J Cell Biol 158: 639-646, 2002.
80. Ushioda R, Hoseki J, Araki K, Jansen G, Thomas DY, and Nagata K. ERdj5 is required as a disulfide reductase for degradation of misfolded proteins in the ER. Science 321: 569-572, 2008.
81. van Ham TJ, Holmberg MA, van der Goot AT, Teuling E, Garcia-Arencibia M, Kim HE, Du D, Thijssen KL, Wiersma M, Burggraaff R, van Bergeijk P, van Rheenen J, Jerre van Veluw G, Hofstra RM, Rubinsztein DC, and Nollen EA. Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity. Cell 142: 601-612, 2010.
82. van Ham TJ, Thijssen KL, Breitling R, Hofstra RM, Plasterk RH, and Nollen EA. C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet 4: e1000027, 2008.
83. Vance JE. Phospholipid synthesis in a membrane fraction associated with mitochondria. J Biol Chem 265: 7248-7256, 1990.
84. Vembar SS and Brodsky JL. One step at a time: endoplasmic reticulum-Associated degradation. Nat Rev Mol Cell Biol 9: 944-957, 2008.
85. Voisine C, Pedersen JS, and Morimoto RI. Chaperone networks: tipping the balance in protein folding diseases. Neurobiol Dis 40: 12-20, 2010.
86. Wang H, Lim PJ, Karbowski M, and Monteiro MJ. Effects of overexpression of huntingtin proteins on mitochondrial integrity. Hum Mol Genet 18: 737-752, 2009.
87. Yamanaka K, Okubo Y, Suzaki T, and Ogura T. Analysis of the two p97/VCP/Cdc48p proteins of Caenorhabditis elegans and their suppression of polyglutamine-induced protein aggregation. J Struct Biol 146: 242-250, 2004.
88. Ye Y, Shibata Y, Yun C, Ron D, and Rapoport TA. Amembrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429: 841-847, 2004.
89. Yoshida H, Matsui T, Hosokawa N, Kaufman RJ, Nagata K, and Mori K. A time-dependent phase shift in the mammalian unfolded protein response. Dev Cell 4: 265-271, 2003.
90. Zdinak LA, Greenberg IB, Szewczyk NJ, Barmada SJ, Cardamone-Rayner M, Hartman JJ, and Jacobson LA. Transgene-coded chimeric proteins as reporters of intracellular proteolysis: starvation-induced catabolism of a lacZ fusion protein in muscle cells of Caenorhabditis elegans. J Cell Biochem 67: 143-153, 1997.